Saturday, 28 May 2022



LATEST NEWS Army vehicle fell into Shyok river Ladakh, 7 killed & several injured Decision to sell land adjacent to Patiala's historical Shri Kedarnath temple completely anti-people : Preneet Kaur The Title Of Akshay Kumar & Manushi Chhillar’s Prithviraj Changed. View Inside Punjab Increases Rates Of Group Insurance Scheme For Govt Employees 7 soldiers killed, 19 injured in Ladakh road accident IPL 2022: Things are falling in place for Royal Challengers Bangalore, says Sanjay Manjrekar French Open : Diego Schwartzman dispatches Grigor Dimitrov, moves to fourth round Deepika Padukone shares heartwarming 'Period Story' to raise awareness PWD Minister Harbhajan Singh ETO conducts surprise checking at Sector 17 offices of department Launch mass movement to save water : Punjab Chief Minister Bhagwant Mann Bollywood Stars Come Forward For The Promotions Of Qureshi Productions' DEHATI DISCO; Now in theatres Test cricket on downward trend, England can really change it : Brendon McCullum Smriti Irani slams Gandhis, says chants of 'Shri Ram' must reach them Udit Narayan shares his experience watching Anuradha Paudwal sing for the first time SS Rajamouli releases glimpse of 'Brahmastra's first song I will consider myself lucky to die alone : Samantha Ruth Prabhu in response to a troll IPL 2022 : Faf du Plessis, Virat Kohli, Glenn Maxwell will have to score runs for Royal Challengers Bangalore to win against Rajasthan Royals, says Akash Chopra Akshay Kumar : I have done almost 650 songs in my career, and I don't ever want to retire Daniel Bruhl, Macaulay Culkin join pandemic thriller 'Rich Flu' Zayn Ibad Khan, Khushi Dubey open up on being part of Hotstar Specials 'Aashiqana' 'The Broken News' trailer exposes gritty reality of the news business


Covid patients relieved of symptoms in 24 hrs after taking antibody cocktail

Coronavirus, COVID 19, Novel Coronavirus, India Fights Corona, Fight Against Corona, Corona Virus Updates, Coronavirus Epidemic, Coronavirus Pandemic, Covaxin, Covishield, Covid-19 Vaccine, Covid-19 Vaccine in India, COVID-19 Vaccination, COVID Vaccination, Stay Home Stay Safe, Stay Home, Social Distancing, Corona virus threat, Coronavirus Vaccine, SARS-CoV-2

Web Admin

Web Admin

5 Dariya News

Hyderabad , 15 Jun 2021

Fifty Covid-19 patients who received single-dose monoclonal antibodies cocktail drug (casirivimab and imdevimab) were relieved of their symptoms within 24 hours of the therapy given at the AIG Hospitals in Hyderabad. "Preliminary analysis shows that these patients are relieved of their symptoms within 24 hours of the monoclonal therapy and their RT-PCR reports also showed viral clearance within a week," Asian Institute of Gastroenterology (AIG) Chairman, Dr D. Nageshwar Reddy, told IANS on Tuesday. This is the first of its kind study in India where experts are looking for the efficacy of this monoclonal antibodies cocktail, especially with the Delta variant (B.1.617), of the virus. "Our plan is to include at least 100 patients for this study. Already 50 patients have been given the drug and we are following up these patients," he said. The patients were given the single dose monoclonal antibodies cocktail drug (casirivimab and imdevimab) within 5 days of their first symptom onset. These patients are in various age groups but majorly 65 plus with comorbidities like diabetes, hypertension, and obesity. Those who were in younger age group were in high-risk category including being on immunosuppressants. According to Dr Reddy, the results till now have been consistent among all these patients. "Studies which were conducted in the US showed that this drug cocktail is effective against the Alpha, Beta and Gamma variants of the virus. The primary objective of the study that we are conducting is to see the efficacy of this monoclonal therapy on the Delta variant (B.1.617) that is now the most prevent strain," he said. The combination of drugs that is being currently used in this antibody cocktail is made by Roche and marketed by Cipla in India. This contains two monoclonal antibodies, Casirivimab and Imdevimab. In India, Zydus recently got the approval to conduct clinical trials by the Subject Expert Committee of the Central Drugs Standard Control Organisation for their antibody cocktail. Currently, the cost of the Roche antibody cocktail comes around Rs 60,000. Patients over 65, obese patients, with uncontrolled diabetes, cardiovascular patients, chronic kidney disease patients and those who are under immunosuppressants like cancer patients are ideal candidates for this treatment. "The timing also must be appropriate where it needs to be given within three to seven days at max. This can be given to patients above 55 if they have heart related issues like hypertension," Dr Reddy said. "Pregnant women and children below 12 years of age are not supposed to be given this treatment as we don't have enough safety data for this subset of patients," he added. Dr Reddy had earlier cautioned against irrational use of antibody cocktails. "This treatment has the potential to increase mutant variants and that is why irrational use of these antibodies' cocktails should be absolutely discouraged," he said. Clinical studies published in peer-reviewed journals including the New England Journal of Medicine have shown that antibody cocktails reduce hospitalisation or death by over 70 per cent, including a drastic reduction in viral clearance. Roche's antibody cocktail was given to then US President Donald Trump when he contracted Covid-19 last year.The doctors say that the cocktail is to be given only in a hospital setting where there is provision to activate the emergency medical system immediately following any infusion-related adverse reaction.


Tags: Coronavirus , COVID 19 , Novel Coronavirus , India Fights Corona , Fight Against Corona , Corona Virus Updates , Coronavirus Epidemic , Coronavirus Pandemic , Covaxin , Covishield , Covid-19 Vaccine , Covid-19 Vaccine in India , COVID-19 Vaccination , COVID Vaccination , Stay Home Stay Safe , Stay Home , Social Distancing , Corona virus threat , Coronavirus Vaccine , SARS-CoV-2



related news




Photo Gallery



Video Gallery



5 Dariya News RNI Code: PUNMUL/2011/49000
© 2011-2022 | 5 Dariya News | All Rights Reserved
Powered by: CDS PVT LTD